Last reviewed · How we verify
Markman Biologics Microsurfaced ADM
Markman Biologics Microsurfaced ADM is an acellular dermal matrix (ADM) product with a modified surface designed to improve integration and reduce complications in reconstructive surgery.
Markman Biologics Microsurfaced ADM is an acellular dermal matrix (ADM) product with a modified surface designed to improve integration and reduce complications in reconstructive and aesthetic surgical applications. Used for Soft tissue reconstruction and augmentation in plastic and reconstructive surgery, Breast reconstruction, Abdominal wall reconstruction.
At a glance
| Generic name | Markman Biologics Microsurfaced ADM |
|---|---|
| Sponsor | McGuire Institute |
| Drug class | Acellular dermal matrix (ADM) / Tissue scaffold |
| Modality | Biologic |
| Therapeutic area | Reconstructive and Aesthetic Surgery |
| Phase | FDA-approved |
Mechanism of action
This is a biologic scaffold derived from human cadaveric skin with the cellular components removed, leaving behind the extracellular matrix. The microsurfacing technology modifies the surface properties to enhance tissue integration, reduce inflammatory response, and improve vascularization when used in reconstructive and plastic surgical applications.
Approved indications
- Soft tissue reconstruction and augmentation in plastic and reconstructive surgery
- Burn wound coverage and reconstruction
Common side effects
- Infection
- Seroma formation
- Graft failure or poor integration
- Inflammatory response
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Markman Biologics Microsurfaced ADM CI brief — competitive landscape report
- Markman Biologics Microsurfaced ADM updates RSS · CI watch RSS
- McGuire Institute portfolio CI